13F-HR filed by Endurant Capital Management LP
Endurant Capital Management LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 34 holding rows worth $114,544,687.
- Accession
- 0001633055-23-000007
- Filer
- CIK 1633055
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 34 entries on the cover page, a total value of $114,544,687 stated on the cover page (in dollars after the unit check, H1), rows summing to $114,544,687 with VALUE read as dollars as filed, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 6,100 | $27,147,318 | dollars as filed | put |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 93,600 | $8,113,248 | dollars as filed | call |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 32,569 | $7,859,877 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 25,816 | $7,243,970 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 49,332 | $5,692,419 | dollars as filed | |
| AGILENT TECHNOLOGIES INC COM | 00846U101 | Stock | 45,762 | $5,502,881 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 58,036 | $4,722,970 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 60,808 | $4,352,029 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 19,169 | $4,308,616 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 43,602 | $3,779,421 | dollars as filed | |
| BECTON DICKINSON & CO | 075887109 | COM | 13,360 | $3,527,174 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 60,991 | $3,299,003 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 31,696 | $2,997,491 | dollars as filed | |
| QIAGEN NV | N72482123 | SHS NEW | 62,708 | $2,823,741 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 5,636 | $2,504,018 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 27,181 | $2,394,646 | dollars as filed | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 32,710 | $2,214,794 | dollars as filed | |
| VENTAS INC COM | 92276F100 | REIT | 41,575 | $1,965,250 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 368,438 | $1,901,140 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 79,471 | $1,676,838 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 175,000 | $1,317,750 | dollars as filed | call |
| ZOETIS INC CL A | 98978V103 | Stock | 7,643 | $1,316,201 | dollars as filed | |
| BRUKER CORP | 116794108 | COM | 15,246 | $1,126,984 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 2,565 | $999,657 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 281,441 | $925,941 | dollars as filed | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 686,143 | $768,480 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 821,038 | $759,460 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 9,153 | $728,945 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 29,282 | $554,894 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 10,741 | $470,993 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 2,850 | $468,968 | dollars as filed | |
| BIOXCEL THERAPEUTICS INC | 09075P105 | COM | 57,100 | $380,286 | dollars as filed | call |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 40,184 | $362,862 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 20,754 | $336,422 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001633055-23-000007 | this filing | 2023-08-14 | acceptance time not in the bulk data set |